{"id":9508,"date":"2019-10-30T12:58:00","date_gmt":"2019-10-30T12:58:00","guid":{"rendered":"https:\/\/jurmed.ro\/medici\/?p=9508"},"modified":"2019-10-30T13:03:06","modified_gmt":"2019-10-30T13:03:06","slug":"interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center","status":"publish","type":"post","link":"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/","title":{"rendered":"Interviu:  Dr. Dan Jinga &#8211; Medic Primar Oncologie, Neolife Medical Center"},"content":{"rendered":"<p><a href=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2019\/10\/Dr.-Dan-Jinga.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-9509 alignleft\" src=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2019\/10\/Dr.-Dan-Jinga-289x300.jpg\" alt=\"\" width=\"289\" height=\"300\" srcset=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2019\/10\/Dr.-Dan-Jinga-289x300.jpg 289w, https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2019\/10\/Dr.-Dan-Jinga.jpg 341w\" sizes=\"auto, (max-width: 289px) 100vw, 289px\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p><em><strong>Dr. Dan Jinga<\/strong><\/em><\/p>\n<ul>\n<li><em><strong>Medic Primar Oncologie, Neolife Medical Center<\/strong><\/em><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p style=\"text-align: justify\"><strong>\u201e\u00cen Rom\u00e2nia, cancerul de s\u00e2n e\u00a0diagnosticat cel mai frecvent \u00een stadii t\u00e2rzii\u201d<\/strong><\/p>\n<p style=\"text-align: justify\"><strong>\u00a0<\/strong><\/p>\n<p style=\"text-align: justify\"><strong><u>Care este rata de supravie<\/u><\/strong><strong><u>\u0163<\/u><\/strong><strong><u>uire \u00een cazul cancerului la s\u00e2n?<\/u><\/strong><\/p>\n<p style=\"text-align: justify\">C\u00e2nd vorbim despre stadii incipiente, stadiile 0, I \u0219i chiar \u0219i II, \u00eendr\u0103znim s\u0103 vorbim de vindecare. E unul dintre cancerele unde ne permitem s\u0103 facem aceste afirma\u0163ii. De aici vine \u0219i necesitatea diagnosticului precoce \u0219i a testelor de screening.<\/p>\n<p style=\"text-align: justify\"><strong><u>Ce este testul de screening?<\/u><\/strong><\/p>\n<p style=\"text-align: justify\">Testul de screening e mai mult dec\u00e2t un diagnostic precoce, este un test popula\u0163ional care se face unei popula\u0163ii \u0163int\u0103, de o anumit\u0103 v\u00e2rst\u0103, pe care o stabile\u0219te o autoritate public\u0103 din fiecare \u0163ar\u0103. Autoritatea public\u0103 stabile\u0219te criteriile de screening dup\u0103 datele de inciden\u0163\u0103 \u0219i mortalitate prin cancerul respective. \u0218i dac\u0103 v\u0103 uita\u0163i pe statistici europene, o s\u0103 vede\u0163i c\u0103 difer\u0103 de la \u0163ar\u0103 la \u0163ar\u0103. Sunt \u0163\u0103ri care \u00ee\u0219i \u00eencep screeningul la 40 de ani, altele abia la 60. \u00cen func\u0163ie de datele accumulate \u00een zonele respective.<\/p>\n<p style=\"text-align: justify\">\u0218i Rom\u00e2nia \u00eencearc\u0103 s\u0103 fac\u0103 func\u0163ional acest program de screening. El exist\u0103. Din p\u0103cate, e adresat unei popula\u0163ii limitate \u00eenc\u0103. Limitate \u0219i din considerente de publicitate, \u00een sensul c\u0103 nu de multe ori am asistat la neutilizarea fondurilor alocate, din lipsa celor care s\u0103 vin\u0103 s\u0103 beneficieze de aceste teste. Se fac eforturi \u0219i s-au f\u0103cut \u00een ultimii 10 ani ca popula\u0163ia supus\u0103 screeningului s\u0103 fie mult mai numeroas\u0103 dec\u00e2t a fost vreodat\u0103. Dar dureaz\u0103.\u00a0 P\u00e2n\u0103 c\u00e2nd vom ajunge la rezultatele din Europa de Vest, unde toat\u0103 popula\u0163ia, trimis\u0103 de medical de familie, la data \u0219i ora precis\u0103 se duce \u0219i \u00ee\u0219i face aceast\u0103 verificare, va mai trece timp. Acesta este screeningul adev\u0103rat. Iar screeningul adev\u0103rat \u00ee\u0163i aduce \u00een prim-plan tumori incipiente, stadii 0 sau I, unde putem s\u0103 \u00eendr\u0103znim s\u0103 spunem de o rat\u0103 de curabilitate uria\u0219\u0103, peste 95%. Merit\u0103 aceast\u0103 investi\u0163ie \u00een timp, \u00een bani, \u00een efort, chiar \u0219i din partea mediei, pentru a ajunge la aceste rezultate. De exemplu, \u00een Statele Unite, datorit\u0103 acestor eforturi de screening derulat \u00een ultimii 30 de ani, un caz din cinci este depistat \u00een stadiul 0. \u00cen Rom\u00e2nia, cazurile de cancer mamar \u00een stadii 0 sunt foarte pu\u0163ine, c\u00e2teva zeci. \u00cen Statele Unite au ajuns la peste 60.000 de cancere \u00een stadiul 0 depistate anual. Toate aceste cancere se trateaz\u0103 mult mai simplu, nu necesit\u0103 tratamentele sofisticate oncologice, necesit\u0103 o opera\u0163ie de bun\u0103 calitate \u0219i\/sau radioterapie acolo unde este nevoie. Se creeaz\u0103 astfel \u0219ansa de a nu face complica\u0163ii superioare multiple din cauza tratamentelor, de a avea o calitatea vie\u0163ii foarte bun\u0103 \u0219i, \u00een acela\u0219i timp, de a nu scoate popula\u0163ia aceasta, marea ei majoritate o popula\u0163ie t\u00e2n\u0103r\u0103, din via\u0163a active, via\u0163a social\u0103.<\/p>\n<p style=\"text-align: justify\"><strong><u>\u00cen Rom\u00e2nia, \u00een ce stadii se diagnosticheaz<\/u><\/strong><strong><u>\u0103<\/u><\/strong><strong><u> cel mai frecvent cancerul de s\u00e2n?<\/u><\/strong><\/p>\n<p style=\"text-align: justify\">Din p\u0103cate, la noi cele mai frecvente sunt stadiile III, care sunt stadii greu curabile, multe dintre ele incurabile. Tot e bine, pentru c\u0103 \u00een ultima vreme a mai sc\u0103zut din inciden\u0163a la diagnostic a stadiilor IV, adic\u0103 stadiile aflate \u00een ultim\u0103 faz\u0103. Tot e un avantaj. Eforturile se v\u0103d, mai ales ale ultimilor 10 ani, \u0219i s\u0103 sper\u0103m c\u0103 \u0219i noi vom trece spre diagnosticul \u00een mas\u0103 al stadiilor I \u0219i II m\u0103car.<\/p>\n<p style=\"text-align: justify\"><strong><u>C\u00e2t de utile sunt caravanele de screening?<\/u><\/strong><\/p>\n<p style=\"text-align: justify\">Aceste caravane exist\u0103. Am participat la mai multe \u00eentruniri. Sunt ale Ministerului S\u0103n\u0103t\u0103\u0163ii, exist\u0103 programe pilot. Nu fac parte din acest program, dar \u0219tiu c\u0103 exist\u0103. Din p\u0103cate, acoperirea lor popula\u0163ional\u0103 este destul de modest\u0103. Adic\u0103 au fost \u0219i date publicate pe anumite zone defavorizate cu rezultate foarte bune, care ar merita luate \u00een considerare \u0219i extinse la nivel na\u0163ional. Deocamdat\u0103 sunt eforturi uria\u0219e pe popula\u0163ii reduse numeric. \u00cens\u0103 programul de depistare precoce al cancerului de s\u00e2n \u0219i cancerului de col uterin al Ministerului S\u0103n\u0103t\u0103\u0163ii este foarte ambi\u0163ios. \u0218i dorin\u0163a noastr\u0103, a tuturor doctorilor, de orice specialitate p\u00e2n\u0103 la urm\u0103 este ca acest program s\u0103 func\u0163ioneze la scar\u0103 na\u0163ional\u0103, a\u0219a cum de altfel se \u00eent\u00e2mpl\u0103 \u00een \u00eentreaga Europ\u0103. Rom\u00e2nia nu face altceva dec\u00e2t s\u0103 \u00eencerce s\u0103 aduc\u0103 medicina rom\u00e2neasc\u0103 acolo unde \u00eei e locul. \u0218i unde a fost \u00eentotdeauna.<\/p>\n<p style=\"text-align: justify\"><strong><u>De la ce v\u00e2rst<\/u><\/strong><strong><u>\u0103<\/u><\/strong><strong><u> poate ap<\/u><\/strong><strong><u>\u0103<\/u><\/strong><strong><u>rea cancerul mamar?<\/u><\/strong><\/p>\n<p style=\"text-align: justify\">Din nefericire, orice cancer poate s\u0103 apar\u0103 la orice v\u00e2rst\u0103. Ne confrunt\u0103m \u00een ultiima vreme cu cazuri ap\u0103rute la v\u00e2rtse foarte mici. Noi suntem separa\u0163i ca speciali\u0219ti, pediatria este separat\u0103 de oncologia adul\u0163ilor. Eu, personal, v\u0103d \u0219i paciente de 25-30 de ani destul de frecvent. A\u0219 vrea s\u0103 nu le v\u0103d, dar din p\u0103cate num\u0103rul lor cre\u0219te. Iar media de v\u00e2rst\u0103 la momentul diagnosticului a sc\u0103zut semnificativ \u00een ultimii 15 ani, a\u0219a \u00eenc\u00e2t avem o medie \u00een jur de 45 de ani.\u00a0 Cu 15 ani \u00een urm\u0103 media era de aproape 60 de ani. 55-60 de ani. Asta e realitatea.<\/p>\n<p style=\"text-align: justify\"><strong><u>Care sunt factorii de risc \u00een apari<\/u><\/strong><strong><u>\u0163<\/u><\/strong><strong><u>ia cancerului la s\u00e2n?<\/u><\/strong><\/p>\n<p style=\"text-align: justify\">Cauzele cancerului, \u00een general, nu sunt cunoscute. Dar pentru c\u0103 este unul dintre cancerele studiate vreme \u00eendelungat\u0103 sunt cunoscu\u0163i factori favorizan\u0163i, anumite cauze care ar putea s\u0103 contribuie la apari\u0163ia cancerului. Exist\u0103 mai nou depistate \u0219i eviden\u0163iate cauzele genetice. Numai c\u0103 aceste cauze genetice sunt foarte rare. Nu constituie mai mult de 5%-10% din totalul cancerelor mamare. A ap\u0103rut no\u0163iunea de consult genetic. Dac\u0103 \u0219tii c\u0103 provii dintr-o familie care are \u00een istoric cancer de s\u00e2n \u0219i ovarian \u2013 vezi Angelina Jolie \u2013 imediat trebuie s\u0103 beneficiezi de consulturi suplimentare, sfat genetic, atitudini diferite fa\u0163\u0103 de popula\u0163ia general\u0103.<\/p>\n<p style=\"text-align: justify\">\u00cen afara factorilor genetici sunt factorii de mediu: poluarea, factorii alimentari, fumatul \u0219i mai ales obezitatea. Toate acestea pot s\u0103 contribuie. Cancerul \u00eentotdeauna are origine plurifactorial\u0103. Cu mici excep\u0163ii, cum ar fi cancerele infec\u0163ioase &#8211; cum e cancerul de col uterin strict legat de infec\u0163ia cu HPV \u2013 \u00een foarte rare cazuri po\u0163i s\u0103 legi o singur\u0103 cauz\u0103 de apari\u0163ia unui cancer. E plurifactorial. Chiar dac\u0103 ai elemente genetice, po\u0163i s\u0103 dezvol\u0163i mai devreme sau mai t\u00e2rziu un cancer \u00een func\u0163ie \u0219i de factorii de mediu. \u0218i lucrul acesta \u00eel \u0219tim foarte bine din faptul c\u0103 inciden\u0163a cancerului mamar este mare \u00een zonele industrializate. Dac\u0103 ne uit\u0103m pe harta lumii, o s\u0103 vede\u0163i c\u0103 cele mai industrializate zone, respectiv cele cu istoria cea mai lung\u0103 de industrializare (bazinul Ruhr din Germania, ora\u0219ele industrial din Marea Britanie sau mai nou coastele Americii, deci New York sau partea cealalt\u0103) sunt zone unde o femeie din patru face cancer mamar. \u0218i la polul opus o s\u0103 g\u0103sim zone din Asia unde cancerul mamar este rar, o femeie din 10-12 ajunge s\u0103 fac\u0103 pe parcursul vie\u0163ii cancer mamar. Aici \u00ee\u0163i arat\u0103 c\u0103 poluarea, elementul alimentar s\u0103 contribuie foarte mult. \u00cen ultimii ani, pe l\u00e2ng\u0103 fumat s-a ad\u0103ugat obezitatea. \u0218i se insist\u0103 foarte mult, pentru c\u0103 \u00een 2017 a ap\u0103rut un studiu clinic populational, \u00een care obezitatea s-a dovedit factor de risc major pentru cel pu\u0163in 15 tumori solide, pe primul loc fiind cancerul mamar, ovarian, colorectal. Deci acesta e un factor deosebit. Bun, acum se \u00eemboln\u0103vesc \u0219i oamenii care tr\u0103iesc \u00een mediul rural, dar inciden\u0163a, posibilitatea lor s\u0103 fac\u0103 acest cancer este net inferioar\u0103 celor care locuiesc \u00een mediul urban \u0219i, mai ales, \u00een mediile urbane poluate. Din nefericire, Bucure\u0219tiul urmeaz\u0103 repede industrializarea european\u0103 \u0219i american\u0103, a\u0219a \u00eenc\u00e2t \u0219i cancerul mamar \u00eencepe s\u0103 devin\u0103 din ce \u00een ce mai frecvent \u00een zona Bucue\u0219tiului \u0219i zonele limitrofe, astfel \u00eenc\u00e2t \u00een momentul de fa\u0163\u0103 asist\u0103m la o cre\u0219tere a num\u0103rului de cazuri. Categoric, \u00een ultimii zece ani cazurile aproape s-au dublat.<\/p>\n<p style=\"text-align: justify\">De asemenea, iradierea. Iradierea poate s\u0103 fie natural\u0103 (terestr\u0103 sau aerian\u0103), dar poate s\u0103 fie \u0219i iradierea artificial\u0103, provocat\u0103 din accidente. \u00cen zonele unde s-au petrecut aceste accidente, inciden\u0163a cancerului \u00een general a crescut \u0219i inciden\u0163a cancerului mamar \u00een particular.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; &nbsp; &nbsp; Dr. Dan Jinga Medic Primar Oncologie, Neolife Medical Center &nbsp; &nbsp; &nbsp; \u201e\u00cen Rom\u00e2nia, cancerul de s\u00e2n e\u00a0diagnosticat cel mai frecvent \u00een stadii t\u00e2rzii\u201d \u00a0 Care este [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":9509,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[276,168],"tags":[],"class_list":["post-9508","post","type-post","status-publish","format-standard","has-post-thumbnail","category-interviu","category-oncologie"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Interviu: Dr. Dan Jinga - Medic Primar Oncologie, Neolife Medical Center<\/title>\n<meta name=\"description\" content=\"Interviu: Dr. Dan Jinga - Medic Primar Oncologie, Neolife Medical Center\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/\" \/>\n<meta property=\"og:locale\" content=\"ro_RO\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Interviu: Dr. Dan Jinga - Medic Primar Oncologie, Neolife Medical Center\" \/>\n<meta property=\"og:description\" content=\"Interviu: Dr. Dan Jinga - Medic Primar Oncologie, Neolife Medical Center\" \/>\n<meta property=\"og:url\" content=\"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/\" \/>\n<meta property=\"og:site_name\" content=\"Jurmed - Medici\" \/>\n<meta property=\"article:published_time\" content=\"2019-10-30T12:58:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-10-30T13:03:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2019\/10\/Dr.-Dan-Jinga.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"341\" \/>\n\t<meta property=\"og:image:height\" content=\"354\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Alina\" \/>\n<meta name=\"twitter:label1\" content=\"Scris de\" \/>\n\t<meta name=\"twitter:data1\" content=\"Alina\" \/>\n\t<meta name=\"twitter:label2\" content=\"Timp estimat pentru citire\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/\"},\"author\":{\"name\":\"Alina\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/1203ddfc75cb6a85fecd32186ee55582\"},\"headline\":\"Interviu: Dr. Dan Jinga &#8211; Medic Primar Oncologie, Neolife Medical Center\",\"datePublished\":\"2019-10-30T12:58:00+00:00\",\"dateModified\":\"2019-10-30T13:03:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/\"},\"wordCount\":1403,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2019\/10\/Dr.-Dan-Jinga.jpg\",\"articleSection\":[\"Interviu\",\"Oncologie\"],\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/\",\"url\":\"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/\",\"name\":\"Interviu: Dr. Dan Jinga - Medic Primar Oncologie, Neolife Medical Center\",\"isPartOf\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2019\/10\/Dr.-Dan-Jinga.jpg\",\"datePublished\":\"2019-10-30T12:58:00+00:00\",\"dateModified\":\"2019-10-30T13:03:06+00:00\",\"author\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/1203ddfc75cb6a85fecd32186ee55582\"},\"description\":\"Interviu: Dr. Dan Jinga - Medic Primar Oncologie, Neolife Medical Center\",\"breadcrumb\":{\"@id\":\"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/#breadcrumb\"},\"inLanguage\":\"ro-RO\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/#primaryimage\",\"url\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2019\/10\/Dr.-Dan-Jinga.jpg\",\"contentUrl\":\"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2019\/10\/Dr.-Dan-Jinga.jpg\",\"width\":341,\"height\":354},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/jurmed.ro\/medici\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Interviu: Dr. Dan Jinga &#8211; Medic Primar Oncologie, Neolife Medical Center\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#website\",\"url\":\"https:\/\/jurmed.ro\/medici\/\",\"name\":\"Jurmed - Medici\",\"description\":\"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/jurmed.ro\/medici\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ro-RO\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/1203ddfc75cb6a85fecd32186ee55582\",\"name\":\"Alina\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ro-RO\",\"@id\":\"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/6d9f8e49326fb2e29a59f96348688ad5b800d4cee212a8329ed5c51ca5d31570?s=96&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/6d9f8e49326fb2e29a59f96348688ad5b800d4cee212a8329ed5c51ca5d31570?s=96&r=g\",\"caption\":\"Alina\"},\"url\":\"https:\/\/jurmed.ro\/medici\/author\/alinad\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Interviu: Dr. Dan Jinga - Medic Primar Oncologie, Neolife Medical Center","description":"Interviu: Dr. Dan Jinga - Medic Primar Oncologie, Neolife Medical Center","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/","og_locale":"ro_RO","og_type":"article","og_title":"Interviu: Dr. Dan Jinga - Medic Primar Oncologie, Neolife Medical Center","og_description":"Interviu: Dr. Dan Jinga - Medic Primar Oncologie, Neolife Medical Center","og_url":"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/","og_site_name":"Jurmed - Medici","article_published_time":"2019-10-30T12:58:00+00:00","article_modified_time":"2019-10-30T13:03:06+00:00","og_image":[{"width":341,"height":354,"url":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2019\/10\/Dr.-Dan-Jinga.jpg","type":"image\/jpeg"}],"author":"Alina","twitter_misc":{"Scris de":"Alina","Timp estimat pentru citire":"7 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/#article","isPartOf":{"@id":"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/"},"author":{"name":"Alina","@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/1203ddfc75cb6a85fecd32186ee55582"},"headline":"Interviu: Dr. Dan Jinga &#8211; Medic Primar Oncologie, Neolife Medical Center","datePublished":"2019-10-30T12:58:00+00:00","dateModified":"2019-10-30T13:03:06+00:00","mainEntityOfPage":{"@id":"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/"},"wordCount":1403,"commentCount":0,"image":{"@id":"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/#primaryimage"},"thumbnailUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2019\/10\/Dr.-Dan-Jinga.jpg","articleSection":["Interviu","Oncologie"],"inLanguage":"ro-RO","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/","url":"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/","name":"Interviu: Dr. Dan Jinga - Medic Primar Oncologie, Neolife Medical Center","isPartOf":{"@id":"https:\/\/jurmed.ro\/medici\/#website"},"primaryImageOfPage":{"@id":"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/#primaryimage"},"image":{"@id":"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/#primaryimage"},"thumbnailUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2019\/10\/Dr.-Dan-Jinga.jpg","datePublished":"2019-10-30T12:58:00+00:00","dateModified":"2019-10-30T13:03:06+00:00","author":{"@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/1203ddfc75cb6a85fecd32186ee55582"},"description":"Interviu: Dr. Dan Jinga - Medic Primar Oncologie, Neolife Medical Center","breadcrumb":{"@id":"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/#breadcrumb"},"inLanguage":"ro-RO","potentialAction":[{"@type":"ReadAction","target":["https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/"]}]},{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/#primaryimage","url":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2019\/10\/Dr.-Dan-Jinga.jpg","contentUrl":"https:\/\/jurmed.ro\/medici\/wp-content\/uploads\/sites\/2\/2019\/10\/Dr.-Dan-Jinga.jpg","width":341,"height":354},{"@type":"BreadcrumbList","@id":"https:\/\/jurmed.ro\/medici\/interviu-dr-dan-jinga-medic-primar-oncologie-neolife-medical-center\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/jurmed.ro\/medici\/"},{"@type":"ListItem","position":2,"name":"Interviu: Dr. Dan Jinga &#8211; Medic Primar Oncologie, Neolife Medical Center"}]},{"@type":"WebSite","@id":"https:\/\/jurmed.ro\/medici\/#website","url":"https:\/\/jurmed.ro\/medici\/","name":"Jurmed - Medici","description":"JURMED \u2013 Jurnal de Sanatate este o publicatie lunara de informare si preventie medicala. Revista si site-ul au un continut bogat de articole si informatii cu adresabilitate catre publicul larg.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/jurmed.ro\/medici\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ro-RO"},{"@type":"Person","@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/1203ddfc75cb6a85fecd32186ee55582","name":"Alina","image":{"@type":"ImageObject","inLanguage":"ro-RO","@id":"https:\/\/jurmed.ro\/medici\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/6d9f8e49326fb2e29a59f96348688ad5b800d4cee212a8329ed5c51ca5d31570?s=96&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/6d9f8e49326fb2e29a59f96348688ad5b800d4cee212a8329ed5c51ca5d31570?s=96&r=g","caption":"Alina"},"url":"https:\/\/jurmed.ro\/medici\/author\/alinad\/"}]}},"_links":{"self":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts\/9508","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/comments?post=9508"}],"version-history":[{"count":2,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts\/9508\/revisions"}],"predecessor-version":[{"id":9511,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/posts\/9508\/revisions\/9511"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/media\/9509"}],"wp:attachment":[{"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/media?parent=9508"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/categories?post=9508"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jurmed.ro\/medici\/wp-json\/wp\/v2\/tags?post=9508"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}